Business of the House

When may we debate the need to prosecute GlaxoSmithKline for suppressing the truth about drug trials, which show that the drug Seroxat is not only useless but produces lethal side effects that have killed many people? The matter was last debated in the House in 2004. The regulatory authority has failed to control GlaxoSmithKline. Such a debate would be an opportunity to congratulate ““Panorama””, Charles Medawar of Social Audit, the Seroxat Users Group, the charity Mind and certain hon. Members on a campaign, which has sadly been ignored for five years.